1/30
Research
The compassionate team behind CAR T cancer breakthroughs
The clinical trial support staff at Penn Medicine and the Abramson Cancer Center have helped execute the team science that brings research discoveries from the lab bench to the bedside.
How British settlers used children as tools of settlement in the British Atlantic
Erica Duncan’s research at Penn’s McNeil Center for Early American Studies focuses on how children became essential to shaping ideas of freedom within the Black Atlantic.
Writers of color are leaving the journalism industry for Substack. Is it better there?
Postdoctoral fellow Nelanthi Hewa spoke to writers and journalists of color about their experiences on the email newsletter platform Substack.
Coverage of civilian casualties in allied countries boosts support for U.S. involvement
Research from Penn’s Annenberg Public Policy Center examines whether media coverage of foreign conflicts affects public opinion about U.S. military, diplomatic, and economic involvement.
Revolutionizing data centers: Penn Engineers’ breakthrough in photonic switching
Researchers have developed a photonic switch that can redirect signals in trillionths of a second with minimal power consumption.
Study shows drop in life expectancy in the Gaza Strip
A collaborative team of international researchers estimate that between Oct. 2023 and Sep. 2024 compared to pre-war levels, life expectancy in the Gaza Strip almost halved.
New quantum sensing technology reveals subatomic signals
Penn Engineers have created a novel approach to detect tiny variations in individual atoms, enabling protein research in drug development.
Breakthroughs in gene editing and expression control with mvGPT
Penn Engineers have created a gene editing tool that can address different genetic diseases in the same cell.
A less clumpy, more complex universe?
Researchers combined cosmological data from two major surveys of the universe’s evolutionary history and found that it may have become “messier and complicated” than expected in recent years.
Science behind genetic testing for identifying risk of opioid misuse remains unproven
A new report from researchers at the Perelman School of Medicine and Crescenz VA Medical Center has evaluated a genetic test for opioid use disorder that recently received pre-marketing approval by the FDA, finding that the genes comprising it do not accurately identify individuals likely to develop the disorder.
In the News
Experts reveal the one hack that will help you finally tackle your to-do list
According to research from the College of Liberal and Professional Studies at the School of Arts & Sciences, scheduling time blocks with breaks to complete different tasks can help achieve the goals of a to-do list.
FULL STORY →
Scientists create tiny anticancer weapons that make tumors destroy themselves
Xiaowei (George) Xu of the Perelman School of Medicine and colleagues have unveiled an innovative approach to cancer treatment that leverages tiny capsules known as small extracellular vesicles to target a specific receptor on tumor cells.
FULL STORY →
Scientists are racing to develop a new bird flu vaccine
Drew Weissman and Scott Hensley of the Perelman School of Medicine are testing a vaccine to prevent a strain of H5N1 bird flu in chickens and cattle.
FULL STORY →
Bird poop may be the key to stopping the next flu pandemic. Here’s why
A study led by Louise H. Moncla of the School of Veterinary Medicine suggests that wild birds are an emerging reservoir for North America’s bird flu virus and that surveillance of migrating birds is critical to stopping future outbreaks.
FULL STORY →
When does your brain think something is worth the wait?
Research by Joe Kable of the School of Arts & Sciences and colleagues finds that subjects with damage to certain regions of the prefrontal cortex are less likely to wait things out.
FULL STORY →
Has RSV vaccine hesitancy subsided?
A survey by the Annenberg Public Policy Center finds that more Americans believe in the effectiveness of vaccines developed to protect newborns and seniors against RSV.
FULL STORY →